Leaderboards/Vascular Tumors and Angiosarcomas

Vascular Tumors and Angiosarcomas

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Hyo Song Kim
Yonsei University
99
2
Costanza Lagrasta
University of Parma
78
3
Jason Yongsheng Chan
Duke-NUS Medical School
78
4
Hidenori Ohnishi
Gifu University
60
5
Weimin Shen
Nanjing Children's Hospital
16

Rising Stars Papers

1
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial
Nature Communications|2024
29 cit.
2
Changes in cell morphology and function induced by the NRAS Q61R mutation in lymphatic endothelial cells
PLoS ONE|2024
4 cit.
3
Effects of Notch signaling on proliferation, angiogenesis, and adipogenesis of hemangioma-derived stem cells
European Journal of Histochemistry|2025
2 cit.
4
CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase
International Journal of Molecular Sciences|2024
1 cit.
5
High-Throughput Transcriptomics Identifies Chemoresistance-Associated Gene Expression Signatures in Human Angiosarcoma
International Journal of Molecular Sciences|2024
1 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Hinako Saito
The University of Tokyo
99
2
Sandra Stickler
Medical University of Vienna
99
3
Wen Yih Aw
University of North Carolina at Chapel Hill
68
4
Yani Wei
Sun Yat-sen University
57
5
Alessandro Cioce
University of Campania "Luigi Vanvitelli"
54
6
Elena Bellan
Unknown
52
7
Jiejun Peng
XinHua Hospital
50
8
Ryan Kanai
Albany Medical Center Hospital
44
9
Dong-Min Yu
University of Colorado Anschutz Medical Campus
44
10
Constance Pirson
de Duve Institute
44

Emerging Leaders Papers

1
Microphysiological model of PIK3CA-driven vascular malformations reveals a role of dysregulated Rac1 and mTORC1/2 in lesion formation
Science Advances|2023
26 cit.
2
Dysfunctional mechanotransduction regulates the progression of PIK3CA-driven vascular malformations
APL Bioengineering|2025
5 cit.
3
Characterization of a pleomorphic rhabdomyosarcoma cell line
Scientific Reports|2025
2 cit.
4
Inhibition of hemangioma development by regulating the VEGF/VEGFR autocrine loop via the miR-494/PTEN pathway
Discover Oncology|2025
2 cit.
5
Primary leiomyosarcoma of bone: a clinicopathologic and immunohistochemical study of 142 cases
Pathologica|2025
2 cit.
6
Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD
Preprints.org|2023
1 cit.
7
Large atypical perilobular hemangioma in the breast: a potential misdiagnosis as angiosarcoma
Diagnostic Pathology|2025
1 cit.
8
IL-13/IL-13Rα2 axis promotes proliferation of angiosarcoma cells
Scientific Reports|2025
1 cit.
9
IL-13/IL-13Rα2 axis promotes proliferation of angiosarcoma cells
bioRxiv (Cold Spring Harbor Laboratory)|2024
0 cit.
10
AMPK Signaling Regulates Epithelioid Hemangioendothelioma Cell Growth
Preprints.org|2025
0 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Elizabeth P. Henske
Brigham and Women's Hospital
99
2
Silvia Stacchiotti
Fondazione IRCCS Istituto Nazionale dei Tumori
96
3
Tak W. Mak
National Cancer Centre Singapore
88
4
Håkon Håkonarson
Children's Hospital of Philadelphia
82
5
Andrew R. Reynolds
Cancer Research UK
74
6
Gordon B. Mills
The University of Texas MD Anderson Cancer Center
74
7
Luca Primo
Candiolo Cancer Institute
74
8
Gary K. Schwartz
Cornell University
71
9
Ludovica Ciuffreda
Istituti di Ricovero e Cura a Carattere Scientifico
69
10
Jürgen Becker
University of Göttingen
61

All-Time Leaders Papers

1
Regulation of tumour necrosis factor signalling: live or let die
Nature reviews. Immunology|2015
994 cit.
2
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Annals of Oncology|2021
955 cit.
3
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
Cancer Research|2009
857 cit.
4
Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
Genes & Development|1998
841 cit.
5
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
Angiogenesis|2014
732 cit.
6
A pan-cancer proteomic perspective on The Cancer Genome Atlas
Nature Communications|2014
630 cit.
7
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
Journal of Clinical Oncology|2009
573 cit.
8
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology|2021
552 cit.
9
Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress
Genes & Development|2011
498 cit.
10
High Frequency of <i>PIK3R1</i> and <i>PIK3R2</i> Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
Cancer Discovery|2011
470 cit.

Reagents for Vascular Tumors and Angiosarcomas

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

C-Peptide Antibody

#4593$317
View Evidence →Cell Signaling Technology

Cyclin Antibody Sampler Kit

#9869$722
View Evidence →Cell Signaling Technology

SynGAP (D78B11) Rabbit Monoclonal Antibody

#5540$160
View Evidence →

🌟 All-Time

Most validated

Agilent/Dako

D2-40

Cited in 7 papers
#M3619
View Evidence →Cell Signaling Technology

Phospho-WIPI2 (Ser413) Antibody

Cited in 5 papers
#13571$362
View Evidence →Cell Signaling Technology

Phospho-Histone H3 (Thr3) (D5G1I) Rabbit Monoclonal Antibody

Cited in 5 papers
#13576$176
View Evidence →